Lyell Immunopharma, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $390.6M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $6.3M | 1.6% |
| Other Investing | $145.9M | 37.4% |
| Other | $238.5M | 61.0% |
| Net Cash Flow | $0 | 0.0% |
Net Cash Flow Breakdown
Total Cash from Operations: $390.6M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $6.3M | 1.6% |
| Other Investing | $145.9M | 37.4% |
| Other | $238.5M | 61.0% |
| Net Cash Flow | $0 | 0.0% |